CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease

CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease

Parkinson’s disease (PD) and other chronic and debilitating neurodegenerative diseases (NDs) impose a substantial medical, emotional, and financial burden on individuals and society. The origin of PD is unknown due to a complex combination of hereditary and environmental risk factors. However, over...

Full description

Bibliographic Details
Main Authors: Mujeeb ur Rahman, Muhammad Bilal, Junaid Ali Shah, Ajeet Kaushik, Pierre-Louis Teissedre, Małgorzata Kujawska
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Pharmaceutics
Subjects:
Parkinson’s
CRISPR-Cas9
gene therapy
delivery
applications
Online Access:https://www.mdpi.com/1999-4923/14/6/1252

Similar Items

Similar Items